Patents by Inventor Nozomi Kuwano

Nozomi Kuwano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACRYLAMIDE COMPOUNDS
    Publication number: 20240109842
    Abstract: Provided is an acrylamide compound, which is useful for the promotion of platelet production from platelet progenitor cells such as megakaryocytes in vitro and represented by general formula [I]: wherein each symbol is as defined in the description.
    Type: Application
    Filed: December 8, 2020
    Publication date: April 4, 2024
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hideki HAYASHI, Ryosuke TAGA, Yuki SAKAMOTO, Nozomi KUWANO, Kurumi MINENO, Kazuhiro OHDACHI, Yusuke FUJIMORI
  • ONCOLYTIC VACCINIA VIRUS DEFICIENT IN LARGE REGION OF GENES
    Publication number: 20230364167
    Abstract: The present invention provides a vaccinia virus which specifically grows in cancer cells and damages cancer cells and use of the virus for cancer treatment. The oncolytic vaccinia is deficient in a region consisting of 7000 to 9000 nucleotides in the genome sequence of a vaccinia virus and does not grow in normal cells, but grows specifically in cancer cells and damages cancer cells specifically.
    Type: Application
    Filed: October 1, 2021
    Publication date: November 16, 2023
    Applicant: NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY
    Inventors: Takafumi NAKAMURA, Nozomi KUWANO, Motomu NAKATAKE, Hiromichi KOUNO
  • VACCINIA VIRUS THAT INDUCES CELL FUSION AND USE THEREOF
    Publication number: 20220313761
    Abstract: This invention provides a vaccinia virus that induces cell fusion between infected cells and a method for producing the same. Such vaccinia virus is deprived of the K2L gene or the HA gene or functions of the K2L gene and the HA gene and is mutated to induce cell fusion between infected cells and induce cell death.
    Type: Application
    Filed: May 12, 2020
    Publication date: October 6, 2022
    Applicants: National University Corporation Tottori University, Evolve Biotherapeutics Co., Ltd.
    Inventors: Takafumi Nakamura, Nozomi Kuwano, Motomu Nakatake, Hajime Kurosaki